Developing an effective pricing strategy in the life sciences sector requires balancing clinical value demonstration, health economics, payer budget constraints, and competitive market positioning. Whether launching a novel cell or gene therapy, a specialty biologic, or a medical device, pharmaceutical and medtech leaders must evaluate gross-to-net price corridors, international reference...
